Analysis of clinical features and outcomes in a Chinese cohort with ALK fusion across pan-cancer: a retrospective study
While ALK fusion partners exhibit tumor-type specificity, ALK-TKIs demonstrate potential efficacy in rare fusions though these findings are exploratory and need validation.